InvestorsHub Logo
Followers 19
Posts 1039
Boards Moderated 0
Alias Born 04/18/2018

Re: None

Tuesday, 11/03/2020 10:11:51 AM

Tuesday, November 03, 2020 10:11:51 AM

Post# of 35961
After a long wait navigating the bureaucracy (Applied 2016) of the USPTO the patent for commercial production of thapsigargin was issued to Phyton today. Now Phyton holds patents for commercial production of thapsigargin in both Europe and United States


PR from 2015:

GenSpera, Inc. (now Inspyr) announced a strategic partnership with Phyton Biotech for the manufacture of thapsigargin, which is derived from the thapsia plant and is the key ingredient in the company's investigational agent mipsagargin.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RBSH News